Prospective Evaluation of AI-ECG for Heart Disease Detection
Recruiting NCT07057466
Study Description
Evaluating the Use of Artificial Intelligence to Detect Heart Disease from ECG Data
Study Details
- Registry ID:
- NCT07057466
- Conditions:
- Valvular Heart Disease Stenosis and Regurgitation (Diagnosis), Pulmonary Hypertension (Diagnosis), Heart Failure With Reduced Ejection Fraction (HFrEF; Diagnosis), Heart Failure With Preserved Ejection Fraction (HFpEF; Diagnosis)
- Phase:
- Target Enrollment:
- 590 participants
- Start Date:
- Age Range:
- 18–90 years
- Healthy Volunteers:
- No
Study Locations (6 sites)
-
Chelsea and Westminster Hospital
London, United Kingdom -
West Middlesex University Hospital
London, United Kingdom -
Hammersmith Hospital
London, United Kingdom -
St Mary's Hospital
London, United Kingdom -
Southmead Hospital
Bristol, United Kingdom -
Bristol Royal Infirmary
Bristol, United Kingdom
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.